There are currently 402 studies in the GENERA database.

Advanced Search

General Information

Document type
  • Peer-reviewed journal article
GE organism
  • maize
GE trait
  • insect resistance
Country
  • USA

Results

Safety for consumption
  • no effect

A negative, double-blind, placebo-controlled challenge to genetically modified corn Open Access

Sutton, SA; Assa'ad, AH; Steinmetz, C; Rothenberg, ME
The Journal of Allergy and Clinical Immunology. 2003 November. 112(5):1011-1012

Link to full text (open access, freely available)

PMID: 14610498 DOI: 10.1016/S0091-6749(03)02024-4

Abstract

[First paragraph in lieu of abstract] To the Editor: Starlink corn is a genetically engineered corn developed by Aventis CropScience (Research Triangle Park, NC) to express an insecticidal protein Cry9c (also known as Bt protein). This protein is derived from the bacterium Bacillus thuringensis and is directed at lepidopteran and coleopteran insects. Starlink corn also contains genes from Streptomyces hygroscopicus, which make the corn tolerant to glufosinate herbicides. In 1998, the US Environmental Protection Agency (EPA) approved registration of Starlink for restricted use as animal feed. In September 2000, the consumers’ group Friends of the Earth announced that traces of Starlink corn DNA were found in taco shells made by Kraft Foods (Phillip Morris, Northfield, Ill), signifying an inadvertent introduction of this transgenic food into the human food supply.1 This initiated the eventual recall of several hundred corn products by the US Food and Drug Administration (FDA), aswell as larger concerns about how this transgenic foodhad entered the human food supply.

Keywords

Starlink; allergy; Bt; patient; placebo; negative; Cry9c; Keith Finger

Funding

Funding source
  • Division of Allergy and Immunology, Cincinati Children's Hospital Medical Center
Funding country
  • United States
Funding type
  • NGO: independent

Links to outside analysis of this resource

Please contact us if you know of an independent summary or analysis of this resource.

Cite this study

MLA

Sutton, SA, AH Assa'ad, C Steinmetz, ME Rothenberg. "A negative, double-blind, placebo-controlled challenge to genetically modified corn." The Journal of Allergy and Clinical Immunology 112.5 (2003): 1011-1012. Web. 25 Sep. 2018.

APA

Sutton, SA., Assa'ad, AH., Steinmetz, C., & Rothenberg, ME. (2003). A negative, double-blind, placebo-controlled challenge to genetically modified corn. The Journal of Allergy and Clinical Immunology, 112(5), 1011-1012. doi:10.1016/S0091-6749(03)02024-4

Please verify citations before use, citations are automatically generated based on information stored within the GENERA database and therefore may or may not be correct.